Petrovsky N - Search Results

1

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant.

Kaushik D, Dhingra S, Patil MT, Piplani S, Khanna V, Honda-Okubo Y, Li L, Fung J, Sakala IG, Salunke DB, Petrovsky N. Kaushik D, et al. Among authors: petrovsky n. Hum Vaccin Immunother. 2020 Aug 2;16(8):1989-1996. doi: 10.1080/21645515.2019.1710409. Epub 2020 Apr 16. Hum Vaccin Immunother. 2020. PMID: 32298200 Free PMC article.

2

Focus on influenza vaccines.

Petrovsky N. Petrovsky N. Hum Vaccin. 2009 Oct;5(10):658-9. doi: 10.4161/hv.5.10.9315. Epub 2009 Oct 21. Hum Vaccin. 2009. PMID: 19667763 No abstract available.

3

Lessons learned from the H1N1 2009 pandemic.

Petrovsky N. Petrovsky N. Hum Vaccin. 2010 Oct;6(10):780-3. doi: 10.4161/hv.6.10.12981. Epub 2010 Oct 1. Hum Vaccin. 2010. PMID: 20935468 Free PMC article.

4

The vaccine renaissance.

Petrovsky N. Petrovsky N. Hum Vaccin. 2011 Feb;7(2):149-52. doi: 10.4161/hv.7.2.14321. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21321480 Free PMC article. No abstract available.

5

Serological responses following influenza A H1N1 2009 infection in adults.

Tan S, Gordon DL, Honda-Okubo Y, Petrovsky N, Phillips P, Huddleston S, Sadlon TA. Tan S, et al. Among authors: petrovsky n. J Infect. 2011 May;62(5):388-93. doi: 10.1016/j.jinf.2011.03.002. Epub 2011 Mar 21. J Infect. 2011. PMID: 21420426

6

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Gordon DL, et al. Among authors: petrovsky n. Vaccine. 2012 Aug 3;30(36):5407-16. doi: 10.1016/j.vaccine.2012.06.009. Epub 2012 Jun 17. Vaccine. 2012. PMID: 22717330 Free PMC article. Clinical Trial.

7

Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.

Honda-Okubo Y, Saade F, Petrovsky N. Honda-Okubo Y, et al. Among authors: petrovsky n. Vaccine. 2012 Aug 3;30(36):5373-81. doi: 10.1016/j.vaccine.2012.06.021. Epub 2012 Jun 20. Vaccine. 2012. PMID: 22728225 Free PMC article.

8

The future of human DNA vaccines.

Li L, Saade F, Petrovsky N. Li L, et al. Among authors: petrovsky n. J Biotechnol. 2012 Dec 31;162(2-3):171-82. doi: 10.1016/j.jbiotec.2012.08.012. Epub 2012 Sep 7. J Biotechnol. 2012. PMID: 22981627 Free PMC article. Review.

9

A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.

Saade F, Honda-Okubo Y, Trec S, Petrovsky N. Saade F, et al. Among authors: petrovsky n. Vaccine. 2013 Apr 8;31(15):1999-2007. doi: 10.1016/j.vaccine.2012.12.077. Epub 2013 Jan 7. Vaccine. 2013. PMID: 23306367 Free PMC article.

10

A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection.

Honda-Okubo Y, Kolpe A, Li L, Petrovsky N. Honda-Okubo Y, et al. Among authors: petrovsky n. Vaccine. 2014 Aug 6;32(36):4651-9. doi: 10.1016/j.vaccine.2014.06.057. Epub 2014 Jun 21. Vaccine. 2014. PMID: 24958701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page